Carolyn M Rutter1, Alan M Zaslavsky2, Eric J Feuer3. 1. Biostatistics Unit, Group Health Research Institute, Seattle, WA USA, and Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle, WA USA (CMR) 2. Department of Health Care Policy Harvard Medical School, Boston, MA USA (AMZ) 3. Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda MD USA (EJF)
Abstract
BACKGROUND: Microsimulation models (MSMs) for health outcomes simulate individual event histories associated with key components of a disease process; these simulated life histories can be aggregated to estimate population-level effects of treatment on disease outcomes and the comparative effectiveness of treatments. Although MSMs are used to address a wide range of research questions, methodological improvements in MSM approaches have been slowed by the lack of communication among modelers. In addition, there are few resources to guide individuals who may wish to use MSM projections to inform decisions. METHODS: . This article presents an overview of microsimulation modeling, focusing on the development and application of MSMs for health policy questions. The authors discuss MSM goals, overall components of MSMs, methods for selecting MSM parameters to reproduce observed or expected results (calibration), methods for MSM checking (validation), and issues related to reporting and interpreting MSM findings(sensitivity analyses, reporting of variability, and model transparency). CONCLUSIONS: . MSMs are increasingly being used to provide information to guide health policy decisions. This increased use brings with it the need for both better understanding of MSMs by policy researchers, and continued improvement in methods for developing and applying MSMs.
BACKGROUND: Microsimulation models (MSMs) for health outcomes simulate individual event histories associated with key components of a disease process; these simulated life histories can be aggregated to estimate population-level effects of treatment on disease outcomes and the comparative effectiveness of treatments. Although MSMs are used to address a wide range of research questions, methodological improvements in MSM approaches have been slowed by the lack of communication among modelers. In addition, there are few resources to guide individuals who may wish to use MSM projections to inform decisions. METHODS: . This article presents an overview of microsimulation modeling, focusing on the development and application of MSMs for health policy questions. The authors discuss MSM goals, overall components of MSMs, methods for selecting MSM parameters to reproduce observed or expected results (calibration), methods for MSM checking (validation), and issues related to reporting and interpreting MSM findings(sensitivity analyses, reporting of variability, and model transparency). CONCLUSIONS: . MSMs are increasingly being used to provide information to guide health policy decisions. This increased use brings with it the need for both better understanding of MSMs by policy researchers, and continued improvement in methods for developing and applying MSMs.
Authors: M Elske van den Akker-van Marle; Marjolein van Ballegooijen; Gerrit J van Oortmarssen; Rob Boer; J Dik F Habbema Journal: J Natl Cancer Inst Date: 2002-02-06 Impact factor: 13.506
Authors: C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D Libby; M Pasmantier; J Koizumi; N Altorki; J P Smith Journal: Oncologist Date: 2001
Authors: C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith Journal: Lancet Date: 1999-07-10 Impact factor: 79.321
Authors: Tumaini R Coker; Helen M DuPlessis; Ramona Davoudpour; Candice Moreno; Michael A Rodriguez; Paul J Chung Journal: Acad Pediatr Date: 2011-11-10 Impact factor: 3.107
Authors: Jeremy D Goldhaber-Fiebert; Rachel E Rubinfeld; Jay Bhattacharya; Thomas N Robinson; Paul H Wise Journal: Med Decis Making Date: 2012-05-29 Impact factor: 2.583
Authors: J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall Journal: Epidemiol Infect Date: 2016-01-12 Impact factor: 2.451
Authors: Mohamad G Fakih; M Todd Greene; Edward H Kennedy; Jennifer A Meddings; Sarah L Krein; Russell N Olmsted; Sanjay Saint Journal: Am J Infect Control Date: 2011-08-25 Impact factor: 2.918
Authors: Melinda M Davis; Siddhartha Nambiar; Maria E Mayorga; Eliana Sullivan; Karen Hicklin; Meghan C O'Leary; Kristen Dillon; Kristen Hassmiller Lich; Yifan Gu; Bonnie K Lind; Stephanie B Wheeler Journal: Prev Med Date: 2019-10-18 Impact factor: 4.018
Authors: Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis Journal: Cancer Date: 2014-02-27 Impact factor: 6.860
Authors: Carolyn M Rutter; Amy B Knudsen; Tracey L Marsh; V Paul Doria-Rose; Eric Johnson; Chester Pabiniak; Karen M Kuntz; Marjolein van Ballegooijen; Ann G Zauber; Iris Lansdorp-Vogelaar Journal: Med Decis Making Date: 2016-01-08 Impact factor: 2.583
Authors: Alyson H Kristensen; Thomas J Flottemesch; Michael V Maciosek; Jennifer Jenson; Gillian Barclay; Marice Ashe; Eduardo J Sanchez; Mary Story; Steven M Teutsch; Ross C Brownson Journal: Am J Prev Med Date: 2014-08-27 Impact factor: 5.043